2-(4-Methylumbelliferyl)-alpha-D-N-acetylneuraminic acid sodium salt hydrate, BioReagent, suitable for fluorescence, >=96.5% (HPLC)

Code: 69587-5mg D2-231

Not available outside of the UK & Ireland.

Application

2′-(4-Methylumbelliferyl)-A-D-N-acetylneuraminic acid or 4-MUNANA is used as a substrate for the development of a microplate-based assay for neuraminidase i...


read more

Your Price
$626.40 5MG

Not available outside of the UK & Ireland.

Application

2′-(4-Methylumbelliferyl)-A-D-N-acetylneuraminic acid or 4-MUNANA is used as a substrate for the development of a microplate-based assay for neuraminidase inhibitors. The fluorogenic substrate 2ʹ-(4-methylumbelliferyl)-A-D-N-acetylneuraminic acid (4-MUNANA) is used to study the molecular mechanisms of aspirin and celecoxib targeting mammalian neuraminidase-1.

Biochem/physiol Actions

Substrate for fluorometric assay of neuraminidase. Used for fluorescent staining of sialidases in PAGE.

General description

2′-(4-Methylumbelliferyl)-A-D-N-acetylneuraminic acid or 4-MUNANA is a synthetic fluorometric substrate that mimics the naturally occurring neuraminidase enzyme substrate. The enzyme-substrate hydrolysis results in the product 4-methylumbelliferone (4-MU), measured fluorometrically.

assay≥96.5% (HPLC)
fluorescenceλex 315 nm; λem 374 nm (pH.7.0), λex 365 nm; λem 445 nm (after cleavage by neuraminidase)
formpowder
impurities≤10% water, ≤0.5% free 4-methylumbelliferone
InChI keyNSQMRVBWXQQIKF-NVRWCLOTSA-M
InChI1S/C21H25NO11.Na.H2O/c1-9-5-16(27)31-15-6-11(3-4-12(9)15)32-21(20(29)30)7-13(25)17(22-10(2)24)19(33-21)18(28)14(26)8-23;;/h3-6,13-14,17-19,23,25-26,28H,7-8H2,1-2H3,(H,22,24)(H,29,30);;1H2/q;+1;/p-1/t13-,14?,17+,18?,19+,21+;;/m0../s1
product lineBioReagent
SMILES stringO.[H]C(O)(CO)[C@]([H])(O)[C@@H]1OC(C[C@H](O)[C@H]1NC(C)=O)(Oc2ccc3C(C)=CC(=O)Oc3c2)C(=O)O[Na]
solubilityH2O: 50 mg/mL, clear, very slightly yellow
storage temp.−20°C
suitabilitysuitable for fluorescence
Code
Description
Unit Size
List Price
Qty
Cas Number76204-02-9
This product has met the following criteria: